Retour
35
Fourchette du Jour
0,27 €
0,27 €
Fourchette 52 Semaines
0,24 €
0,35 €
Volume
100
Moyenne 50J / 200J
0,27 €
/
0,27 €
Clôture Précédente
0,27 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,1 | 0,3 |
| P/B | 0,1 | 2,9 |
| ROE % | -1,6 | 3,7 |
| Net Margin % | -2,3 | 3,8 |
| Rev Growth 5Y % | -6,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,19 €
0,18 € – 0,20 €
|
15 B | 1 |
| FY2027 |
0,16 €
0,15 € – 0,17 €
|
15 B | 1 |
| FY2026 |
0,11 €
0,11 € – 0,12 €
|
14 B | 1 |
Points Clés
Revenue declined -6,82% annually over 5 years
Earnings declined -716,35% over the past year
Debt/Equity of 0,12 — conservative balance sheet
Generating 2,07B in free cash flow
PEG of 0,04 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,17%
Croissance
Revenue Growth (5Y)
-6,82%
Revenue (1Y)-12,99%
Earnings (1Y)-716,35%
FCF Growth (3Y)91,45%
Qualité
Return on Equity
-1,60%
ROIC0,97%
Net Margin-2,32%
Op. Margin2,07%
Sécurité
Debt / Equity
0,12
Current Ratio2,29
Interest Coverage3,08
Valorisation
P/E Ratio
-4,13
P/B Ratio0,07
EV/EBITDA-0,59
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12,99% | Revenue Growth (3Y) | -10,97% |
| Earnings Growth (1Y) | -716,35% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6,82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14,36B | Net Income (TTM) | -333,24M |
| ROE | -1,60% | ROA | -1,03% |
| Gross Margin | 48,09% | Operating Margin | 2,07% |
| Net Margin | -2,32% | Free Cash Flow (TTM) | 2,07B |
| ROIC | 0,97% | FCF Growth (3Y) | 91,45% |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 2,29 |
| Interest Coverage | 3,08 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | -4,13 | P/B Ratio | 0,07 |
| P/S Ratio | 0,10 | PEG Ratio | 0,04 |
| EV/EBITDA | -0,59 | Dividend Yield | 0,04% |
| Market Cap | 1,38B | Enterprise Value | -175,02M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14,36B | 16,51B | 18,12B | 14,30B | 19,05B |
| Net Income | -333,24M | 54,07M | 1,29B | 764,49M | 1,93B |
| EPS (Diluted) | -0,07 | 0,01 | 0,26 | 0,15 | 0,38 |
| Gross Profit | 6,91B | 7,86B | 9,27B | 7,20B | 11,83B |
| Operating Income | 297,75M | 335,59M | 1,43B | 1,06B | 2,75B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 32,36B | 35,06B | 37,07B | 35,62B | 36,39B |
| Total Liabilities | 8,94B | 11,13B | 13,13B | 12,67B | 13,73B |
| Shareholders' Equity | 20,48B | 21,20B | 21,16B | 20,17B | 19,72B |
| Total Debt | 2,49B | 4,02B | 5,16B | 5,04B | 5,06B |
| Cash & Equivalents | 4,05B | 3,87B | 3,02B | 3,07B | 2,89B |
| Current Assets | 17,72B | 18,84B | 19,80B | 17,97B | 18,20B |
| Current Liabilities | 7,74B | 7,80B | 9,33B | 10,10B | 8,76B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#567 of 827
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026